oxazoles and hydroxyurea
oxazoles has been researched along with hydroxyurea in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bergeron, RJ; Ingeno, MJ | 1 |
| Carlson, RP; Glaser, K; Grimes, D; Gunawan, I; Hartman, DA; Howell, R; Kanzelberger, M; Malamas, MS; Nelson, JA; Shah, U | 1 |
| Auzzas, L; Giannini, G; Hanessian, S; Marzi, M; Vinci, V | 1 |
| Iwakiri, D; Kamiya, M; Kanda, T; Maruo, S; Takada, K | 1 |
Other Studies
4 other study(ies) available for oxazoles and hydroxyurea
| Article | Year |
|---|---|
Microbial iron chelator-induced cell cycle synchronization in L1210 cells: potential in combination chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Division; Cell Survival; Deferoxamine; Hydroxyurea; Iron Chelating Agents; Kinetics; Leukemia L1210; Mice; Oxazoles | 1987 |
Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Bronchoconstriction; Guinea Pigs; Humans; Hydroxyurea; Leukotriene B4; Lipoxygenase Inhibitors; Macrophages; Mice; Molecular Structure; Monocytes; Oxazoles; Rats; Structure-Activity Relationship; Thiazoles | 1996 |
Exploring alternative Zn-binding groups in the design of HDAC inhibitors: squaric acid, N-hydroxyurea, and oxazoline analogues of SAHA.
Topics: Alkynes; Cyclobutanes; Drug Design; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Hydroxyurea; Molecular Structure; Oxazoles; Vorinostat; Zinc | 2006 |
Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids.
Topics: Cell Line, Tumor; Cell Nucleus; Chromatids; Chromosomal Proteins, Non-Histone; Diketopiperazines; DNA Replication; Enzyme Inhibitors; Epstein-Barr Virus Nuclear Antigens; G2 Phase; Gene Dosage; Genome, Viral; Green Fluorescent Proteins; Herpesvirus 4, Human; Humans; Hydroxyurea; In Situ Hybridization, Fluorescence; Marine Toxins; Mitosis; Models, Genetic; Oxazoles; Piperazines; Plasmids; Topoisomerase II Inhibitors | 2007 |